Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5836968 | 0.83 | PTGS1 (0.49) | CA14POLBALDH1A1MEN1KMT2A | |
| SCHEMBL21222710 | 0.81 | DNM1 (0.46) | HPGDDNM1CA14KDM4EPAOX | |
| SCHEMBL10201764 | 0.81 | DNM1 (0.49) | HPGDDNM1CA14KDM4EPAOX | |
| SCHEMBL24292483 | 0.80 | HPGD (0.41) | HPGDDNM1CA14KDM4EPAOX | |
| Hydrochloric Acid SCHEMBL22729366 | 0.80 | DNM1 (0.45) | HPGDDNM1CA14KDM4EPAOX | |
| SCHEMBL23922070 | 0.79 | DNM1 (0.47) | HPGDDNM1CA14KDM4EPAOX | |
| SCHEMBL20710627 | 0.79 | HPGD (0.43) | HPGDDNM1CA14KDM4EPAOX | |
| SCHEMBL13808536 | 0.79 | DNM1 (0.45) | HPGDDNM1CA14KDM4EPAOX | |
| SCHEMBL291397 | 0.79 | ALDH1A1 (0.41) | CA14KDM4EPOLBALDH1A1MEN1 | |
| SCHEMBL2138113 | 0.78 | DNM1 (0.46) | HPGDDNM1CA14KDM4EPAOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10456349-B2 | Product for keratin fibers, containing at least one copolymer based on vinylpyrrolidone and at least one copolymer based on acrylates | HENKEL AG & CO. KGAA (DE) | 2019-10-29 | — | — | US | disclosed |
| US-20180064627-A1 | PRODUCT FOR KERATIN FIBERS, CONTAINING AT LEAST ONE COPOLYMER BASED ON VINYLPYRROLIDONE AND AT LEAST ONE COPOLYMER BASED ON ACRYLATES | HENKEL AG & CO. KGAA (DE) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180064627-A1 | PRODUCT FOR KERATIN FIBERS, CONTAINING AT LEAST ONE COPOLYMER BASED ON VINYLPYRROLIDONE AND AT LEAST ONE COPOLYMER BASED ON ACRYLATES | KRT18, CUTA, ACR | HPGD 326/4885DNM1 4303/4885CA14 1563/4885 |
| US-10456349-B2 | Product for keratin fibers, containing at least one copolymer based on vinylpyrrolidone and at least one copolymer based on acrylates | KRT18, CUTA, ACR | HPGD 321/4885DNM1 4215/4885CA14 1629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.